Publications by authors named "Mui Cheung"

Claim this Profile
I
Identification of Diarylurea Inhibitors of the Cardiac-Specific Kinase TNNI3K by Designing Selectivity Against VEGFR2, p38α, and B-Raf.
Jaclyn R Patterson, Alan P Graves, Patrick Stoy, Mui Cheung, Tina A Desai

J Med Chem· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Orally Bioavailable Ligand Efficient Quinazolindiones as Potent and Selective Tankyrases Inhibitors.
Donghui Qin, Xiaojuan Lin, Zhi Liu, Yan Chen, Zhiliu Zhang, Mui Cheung

ACS Med Chem Lett· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of GSK2798745: A Clinical Candidate for Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4).
Carl A Brooks, Linda S Barton, David J Behm, Hilary S Eidam, Ryan M Fox, Mui Cheung

ACS Med Chem Lett· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enteric RET inhibition attenuates gastrointestinal secretion and motility via cholinergic signaling in rat colonic mucosal preparations.
John P Russell, Ehsan Mohammadi, Casey Ligon, Rocco Latorre, Anthony C Johnson, Mui Cheung

Neurogastroenterol Motil· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Potential of RET Kinase Inhibition for Irritable Bowel Syndrome: A Preclinical Investigation in Rodent Models of Colonic Hypersensitivity.
John P Russell, Ehsan Mohammadi, Casey O Ligon, Anthony C Johnson, Michael D Gershon, Mui Cheung

J Pharmacol Exp Ther· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBS.
Hilary Schenck Eidam, John Russell, Kaushik Raha, Michael DeMartino, Donghui Qin, Mui Cheung

ACS Med Chem Lett· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Tetralones as Potent and Selective Inhibitors of Acyl-CoA:Diacylglycerol Acyltransferase 1.
Mui Cheung, Raghuram S Tangirala, Sridhar R Bethi, Hemant V Joshi, Jennifer L Ariazi

ACS Med Chem Lett· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR2 agonism reverses chemotherapy-induced neutropenia in .
Nicholas J Laping, Michael P DeMartino, Joshua E Cottom, Jeffrey M Axten, John G Emery, Mui Cheung

Blood Adv· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PROPERTIES OF THE TRPV4 AGONIST GSK1016790A AND the TRPV4 ANTAGONIST GSK2193874.
Kevin S Thorneloe, Mui Cheung, Dennis A Holt, Robert N Willette

Physiol Rev· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4.
Mui Cheung, Weike Bao, David J Behm, Carl A Brooks, Michael J Bury

ACS Med Chem Lett· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Purines and 7-Deazapurines as Potent and Selective Type I Inhibitors of Troponin I-Interacting Kinase (TNNI3K).
Brian G Lawhorn, Joanne Philp, Yongdong Zhao, Christopher Louer, Marlys Hammond, Mui Cheung

J Med Chem· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRPV4 inhibition counteracts edema and inflammation and improves pulmonary function and oxygen saturation in chemically induced acute lung injury.
Shrilatha Balakrishna, Weifeng Song, Satyanarayana Achanta, Stephen F Doran, Boyi Liu, Mui Cheung

Am J Physiol Lung Cell Mol Physiol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a high-throughput screen to detect inhibitors of TRPS1 sumoylation.
Martin Brandt, Lawrence M Szewczuk, Hong Zhang, Xuan Hong, Patricia M McCormick, Mui H Cheung

Assay Drug Dev Technol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of a Novel Series of TRPV4 Antagonists with In Vivo Activity in a Model of Pulmonary Edema.
Mark A Hilfiker, Tram H Hoang, Johan Cornil, Hilary S Eidam, Daniel S Matasic, Mui Cheung

ACS Med Chem Lett· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure.
Kevin S Thorneloe, Mui Cheung, Weike Bao, Hasan Alsaid, Stephen Lenhard

Sci Transl Med· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties.
Tara R Rheault, Kelly H Donaldson, Jennifer G Badiang-Alberti, Ronda G Davis-Ward, C Webb Andrews, Mui Cheung

Bioorg Med Chem Lett· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding.
Kyle A Emmitte, George M Adjabeng, C Webb Andrews, Jennifer G Badiang Alberti, Ramesh Bambal, Mui Cheung

Bioorg Med Chem Lett· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of thiophene inhibitors of polo-like kinase.
Kyle A Emmitte, C Webb Andrews, Jennifer G Badiang, Ronda G Davis-Ward, Hamilton D Dickson, Mui Cheung

Bioorg Med Chem Lett· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and optimization of imidazo[1,2-a]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R).
Kyle A Emmitte, Brian J Wilson, Erich W Baum, Holly K Emerson, Kevin W Kuntz, Mui Cheung

Bioorg Med Chem Lett· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of potent, selective sulfonylfuran urea endothelial lipase inhibitors.
Krista B Goodman, Michael J Bury, Mui Cheung, Maria A Cichy-Knight, Sarah E Dowdell

Bioorg Med Chem Lett· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitors.
Mui Cheung, Philip A Harris, Jennifer G Badiang, Gregory E Peckham, Stanley D Chamberlain

Bioorg Med Chem Lett· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor.
Philip A Harris, Amogh Boloor, Mui Cheung, Rakesh Kumar, Renae M Crosby

J Med Chem· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors.
Masaichi Hasegawa, Naohiko Nishigaki, Yoshiaki Washio, Kazuya Kano, Philip A Harris, Mui Cheung

J Med Chem· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity.
Rakesh Kumar, Victoria B Knick, Sharon K Rudolph, Jennifer H Johnson, Renae M Crosby, Mui Cheung

Mol Cancer Ther· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel structural motifs consisting of chiral thiazolines: synthesis, molecular recognition, and anticancer activity.
Fu She Han, Hiroyuki Osajima, Mui Cheung, Hidetoshi Tokuyama, Tohru Fukuyama

Chemistry· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis